Importantly, the work presented here represents the most comprehensive of only a handful of analyses of the effects of mRNA A-to-I editing on miRNA targeting published to date [30–32], and represents only the second ever experimental evidence indicating that the modulation of miRNA targeting through ADAR editing may directly contribute to breast cancer pathology [33]. The gene discussed is ADAR; the disease is breast carcinoma.